Concepts (163)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Emergency Medicine | 5 | 2017 | 1196 | 0.460 |
Why?
|
| International Educational Exchange | 2 | 2010 | 49 | 0.430 |
Why?
|
| Testicular Neoplasms | 2 | 2009 | 801 | 0.430 |
Why?
|
| Emergency Medical Services | 3 | 2012 | 1925 | 0.390 |
Why?
|
| Teratocarcinoma | 1 | 2009 | 16 | 0.350 |
Why?
|
| Fellowships and Scholarships | 2 | 2010 | 1116 | 0.320 |
Why?
|
| Homeodomain Proteins | 3 | 2013 | 2414 | 0.320 |
Why?
|
| Y Chromosome | 1 | 2009 | 205 | 0.300 |
Why?
|
| Education, Medical, Graduate | 3 | 2010 | 2363 | 0.280 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2012 | 995 | 0.270 |
Why?
|
| Education, Professional | 1 | 2005 | 51 | 0.250 |
Why?
|
| Neoplasms, Germ Cell and Embryonal | 1 | 2009 | 494 | 0.230 |
Why?
|
| Community Networks | 1 | 2005 | 201 | 0.220 |
Why?
|
| Embryonic Stem Cells | 1 | 2009 | 1262 | 0.200 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2012 | 2828 | 0.200 |
Why?
|
| Quality Improvement | 2 | 2017 | 3836 | 0.180 |
Why?
|
| Equipment and Supplies, Hospital | 1 | 2020 | 59 | 0.180 |
Why?
|
| Curriculum | 3 | 2010 | 3718 | 0.170 |
Why?
|
| Health Policy | 1 | 2012 | 2677 | 0.170 |
Why?
|
| Transcription Factors | 3 | 2013 | 12103 | 0.160 |
Why?
|
| International Cooperation | 1 | 2005 | 1433 | 0.150 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2014 | 8515 | 0.150 |
Why?
|
| Triage | 1 | 2004 | 987 | 0.150 |
Why?
|
| Prostate | 3 | 2014 | 1793 | 0.140 |
Why?
|
| Prostatic Neoplasms | 3 | 2014 | 11345 | 0.130 |
Why?
|
| Consensus Sequence | 2 | 2014 | 365 | 0.120 |
Why?
|
| Proto-Oncogene Proteins c-pim-1 | 1 | 2014 | 32 | 0.120 |
Why?
|
| Thiazolidines | 1 | 2014 | 69 | 0.120 |
Why?
|
| NFI Transcription Factors | 1 | 2014 | 42 | 0.120 |
Why?
|
| Health Services Accessibility | 1 | 2012 | 5397 | 0.120 |
Why?
|
| Receptor Activity-Modifying Protein 1 | 1 | 2013 | 16 | 0.110 |
Why?
|
| Hepatocyte Nuclear Factor 3-alpha | 1 | 2014 | 165 | 0.110 |
Why?
|
| Prostatic Intraepithelial Neoplasia | 1 | 2012 | 81 | 0.100 |
Why?
|
| Health Personnel | 1 | 2005 | 3310 | 0.100 |
Why?
|
| Mice, 129 Strain | 1 | 2012 | 372 | 0.090 |
Why?
|
| Acetylcysteine | 1 | 2012 | 264 | 0.090 |
Why?
|
| Germ Layers | 1 | 2011 | 71 | 0.090 |
Why?
|
| Crowding | 1 | 2011 | 142 | 0.090 |
Why?
|
| Mice, Congenic | 1 | 2009 | 97 | 0.090 |
Why?
|
| Patient Transfer | 1 | 2017 | 779 | 0.090 |
Why?
|
| Biphenyl Compounds | 1 | 2014 | 992 | 0.080 |
Why?
|
| Inbreeding | 1 | 2009 | 48 | 0.080 |
Why?
|
| Chromosomes, Mammalian | 1 | 2009 | 146 | 0.080 |
Why?
|
| Medical Errors | 1 | 2017 | 1255 | 0.080 |
Why?
|
| Prostatic Hyperplasia | 1 | 2012 | 530 | 0.080 |
Why?
|
| Faculty, Medical | 2 | 2008 | 1192 | 0.080 |
Why?
|
| Neoplasm Transplantation | 1 | 2012 | 2014 | 0.080 |
Why?
|
| Blastocyst | 1 | 2011 | 433 | 0.070 |
Why?
|
| Myocardial Infarction | 2 | 2008 | 11891 | 0.070 |
Why?
|
| Base Sequence | 3 | 2014 | 12446 | 0.070 |
Why?
|
| Binding Sites | 2 | 2014 | 6048 | 0.070 |
Why?
|
| Mice, SCID | 1 | 2012 | 2627 | 0.070 |
Why?
|
| Quality of Health Care | 3 | 2017 | 4360 | 0.070 |
Why?
|
| Internationality | 1 | 2011 | 1004 | 0.070 |
Why?
|
| Commonwealth of Independent States | 1 | 2005 | 3 | 0.070 |
Why?
|
| Ventricular Fibrillation | 1 | 2008 | 539 | 0.070 |
Why?
|
| World Health Organization | 1 | 2012 | 1312 | 0.060 |
Why?
|
| Directories as Topic | 1 | 2005 | 8 | 0.060 |
Why?
|
| Cell Separation | 1 | 2011 | 1720 | 0.060 |
Why?
|
| Blood Pressure Monitors | 1 | 2004 | 33 | 0.060 |
Why?
|
| International Agencies | 1 | 2005 | 244 | 0.060 |
Why?
|
| Antioxidants | 1 | 2012 | 1667 | 0.060 |
Why?
|
| Up-Regulation | 1 | 2013 | 4122 | 0.060 |
Why?
|
| Emergency Medical Technicians | 1 | 2005 | 118 | 0.060 |
Why?
|
| Critical Illness | 1 | 2017 | 2709 | 0.060 |
Why?
|
| Mice | 7 | 2014 | 81208 | 0.060 |
Why?
|
| Urban Health Services | 1 | 2004 | 177 | 0.060 |
Why?
|
| Intensive Care Units | 1 | 2017 | 3736 | 0.050 |
Why?
|
| Gene Regulatory Networks | 1 | 2012 | 1741 | 0.050 |
Why?
|
| Accidents, Traffic | 1 | 2008 | 814 | 0.050 |
Why?
|
| Federal Government | 1 | 2005 | 267 | 0.050 |
Why?
|
| Police | 1 | 2005 | 156 | 0.050 |
Why?
|
| Emergency Service, Hospital | 2 | 2013 | 7818 | 0.050 |
Why?
|
| Education, Medical, Continuing | 1 | 2008 | 830 | 0.050 |
Why?
|
| Developing Countries | 2 | 2012 | 2868 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 2 | 2012 | 22023 | 0.050 |
Why?
|
| Cost of Illness | 1 | 2012 | 1940 | 0.050 |
Why?
|
| Transcription, Genetic | 2 | 2014 | 7593 | 0.050 |
Why?
|
| Quantitative Trait Loci | 1 | 2009 | 2101 | 0.050 |
Why?
|
| Acute Disease | 1 | 2012 | 7269 | 0.050 |
Why?
|
| Sequence Analysis, DNA | 1 | 2012 | 4713 | 0.050 |
Why?
|
| Mice, Transgenic | 1 | 2012 | 9530 | 0.040 |
Why?
|
| Wounds and Injuries | 1 | 2012 | 2477 | 0.040 |
Why?
|
| Animals | 7 | 2014 | 167963 | 0.040 |
Why?
|
| Shock, Cardiogenic | 1 | 2004 | 734 | 0.040 |
Why?
|
| Program Development | 1 | 2005 | 1297 | 0.040 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2014 | 5643 | 0.040 |
Why?
|
| Emergencies | 1 | 2004 | 1211 | 0.040 |
Why?
|
| Stem Cells | 1 | 2011 | 3523 | 0.040 |
Why?
|
| Cell Line | 1 | 2012 | 15620 | 0.040 |
Why?
|
| Length of Stay | 1 | 2011 | 6479 | 0.040 |
Why?
|
| Myocardial Ischemia | 1 | 2008 | 2164 | 0.040 |
Why?
|
| Male | 11 | 2017 | 359744 | 0.040 |
Why?
|
| Patient Admission | 2 | 2017 | 1386 | 0.030 |
Why?
|
| Humans | 17 | 2020 | 760621 | 0.030 |
Why?
|
| Down-Regulation | 2 | 2014 | 2913 | 0.030 |
Why?
|
| Schools | 1 | 2005 | 1480 | 0.030 |
Why?
|
| Rats | 1 | 2012 | 23711 | 0.030 |
Why?
|
| Electrocardiography | 2 | 2008 | 6414 | 0.030 |
Why?
|
| Hospitals | 2 | 2020 | 3928 | 0.030 |
Why?
|
| Androgen-Binding Protein | 1 | 2014 | 10 | 0.030 |
Why?
|
| United States | 5 | 2011 | 72461 | 0.030 |
Why?
|
| Cell Proliferation | 3 | 2014 | 10446 | 0.030 |
Why?
|
| Genes, myc | 1 | 2014 | 395 | 0.030 |
Why?
|
| Hospital Design and Construction | 1 | 2013 | 33 | 0.030 |
Why?
|
| Europe | 2 | 2011 | 3441 | 0.030 |
Why?
|
| Heart Rate | 1 | 2004 | 4179 | 0.030 |
Why?
|
| Ambulances | 1 | 2013 | 92 | 0.030 |
Why?
|
| Cell Hypoxia | 1 | 2014 | 658 | 0.030 |
Why?
|
| Hong Kong | 1 | 2011 | 162 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 2014 | 13630 | 0.020 |
Why?
|
| Genes, Neoplasm | 1 | 2013 | 370 | 0.020 |
Why?
|
| Protein Binding | 2 | 2014 | 9335 | 0.020 |
Why?
|
| Denmark | 1 | 2013 | 760 | 0.020 |
Why?
|
| Protein Interaction Mapping | 1 | 2014 | 617 | 0.020 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2014 | 1173 | 0.020 |
Why?
|
| Educational Measurement | 2 | 2008 | 1248 | 0.020 |
Why?
|
| Organ Specificity | 1 | 2014 | 1955 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2013 | 1617 | 0.020 |
Why?
|
| Program Evaluation | 2 | 2008 | 2493 | 0.020 |
Why?
|
| Australia | 1 | 2011 | 1289 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2009 | 17790 | 0.020 |
Why?
|
| HeLa Cells | 1 | 2014 | 3105 | 0.020 |
Why?
|
| Receptors, Androgen | 1 | 2014 | 1077 | 0.020 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2014 | 1356 | 0.020 |
Why?
|
| Mice, Nude | 1 | 2013 | 3607 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2014 | 4035 | 0.020 |
Why?
|
| Prospective Studies | 2 | 2017 | 54303 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2014 | 3584 | 0.020 |
Why?
|
| CpG Islands | 1 | 2011 | 1221 | 0.020 |
Why?
|
| MAP Kinase Signaling System | 1 | 2013 | 1484 | 0.020 |
Why?
|
| Canada | 1 | 2011 | 2128 | 0.020 |
Why?
|
| Italy | 1 | 2008 | 841 | 0.020 |
Why?
|
| Health Care Surveys | 1 | 2013 | 2435 | 0.020 |
Why?
|
| Gene Expression Regulation | 2 | 2014 | 11903 | 0.020 |
Why?
|
| Gene Deletion | 1 | 2012 | 2668 | 0.020 |
Why?
|
| Reactive Oxygen Species | 1 | 2012 | 2138 | 0.010 |
Why?
|
| Reference Standards | 1 | 2008 | 1004 | 0.010 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2014 | 2919 | 0.010 |
Why?
|
| Pluripotent Stem Cells | 1 | 2011 | 792 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2017 | 10182 | 0.010 |
Why?
|
| Female | 4 | 2017 | 391270 | 0.010 |
Why?
|
| Decision Making | 1 | 2017 | 3925 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2014 | 5785 | 0.010 |
Why?
|
| Oxidative Stress | 1 | 2012 | 3106 | 0.010 |
Why?
|
| Certification | 1 | 2005 | 421 | 0.010 |
Why?
|
| Pandemics | 1 | 2020 | 8624 | 0.010 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2011 | 3604 | 0.010 |
Why?
|
| Middle Aged | 3 | 2017 | 220352 | 0.010 |
Why?
|
| Apoptosis | 1 | 2014 | 9501 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2011 | 17624 | 0.010 |
Why?
|
| Hospital Mortality | 1 | 2011 | 5425 | 0.010 |
Why?
|
| DNA Methylation | 1 | 2011 | 4373 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2013 | 16939 | 0.010 |
Why?
|
| Stents | 1 | 2008 | 3314 | 0.010 |
Why?
|
| Time Factors | 1 | 2017 | 40165 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2011 | 9411 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2011 | 11481 | 0.010 |
Why?
|
| Clinical Competence | 1 | 2008 | 4783 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2013 | 25942 | 0.010 |
Why?
|
| Aged | 1 | 2004 | 169152 | 0.010 |
Why?
|
| Child | 1 | 2013 | 79806 | 0.000 |
Why?
|
| Adult | 1 | 2013 | 219994 | 0.000 |
Why?
|
Concepts
(163)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(14)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_